| | 108641-82-3 Basic information More.. |
| Product Name: | DL-HOMOCYSTINE (3,3,3',3',4,4,4',4'-D8) | | Synonyms: | DL-HOMOCYSTINE (3,3,3',3',4,4,4',4'-D8);DL-HOMOCYSTINE-3,3,3',4,4,4',4-D8;DL-HoMocystine-d8;DL-Homocystine-3,3,3',3',4,4,4',4'-d8;DL-Homocystine-3,3,3′,3′,4,4,4′,4′-d8 in 0.1 M HCl;D8-DL-Homocystine;DL-Homocystine (3,3,3′,3′,4,4,4′,4′-D?, 98%);Dl-Homocystine-3,3,3’,3’,4,4,4’,4’-D8 (Standard) | | CAS: | 108641-82-3 | | MF: | C8H8D8N2O4S2 | | MW: | 276.41 | | EINECS: | | | Mol File: | 108641-82-3.mol |  |
Use
Dl-Homocystine (3,3,3',3',4,4,4',4'-D8), Labelled DL-Homocystine is used in the synthesis of potential antitumor agents through inhibition of L-asparagine. There is growing clinical evidence that elevated homocysteine levels are associated with an increased risk of venous and arterial thrombosis.
|
|
108641-82-3
Recommend
Suppliers |
|
|
Recommend You Select Member Companies |
|
|